Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis

References

• Vaes G. Cartilage and bone tissue damage in arthritis: cellular co‐operation and enzymatic mechanisms. Scand J Rheumatol Suppl 1981; 40: 65–71
   PubMedGoogle Scholar
• Cha H. S., Kim T. J., Kim J. Y., Lee M. H., Jeon C. H., Kim J., et al. Autoantibodies to glucose‐6‐phosphate isomerase are elevated in the synovial fluid of rheumatoid arthritis patients. Scand J Rheumatol 2004; 33: 179–84
   PubMed Web of Science ®Google Scholar
• Gysen P., Malaise M., Gaspar S., Franchimont P. Measurement of proteoglycans, elastase, collagenase and protein in synovial fluid in inflammatory and degenerative arthropathies. Clin Rheumatol 1985; 4: 39–50
   PubMedGoogle Scholar
• Walakovits L. A., Moore V. L., Bhardwaj N., Gallick G. S., Lark M. W. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992; 35: 35–42
   PubMed Web of Science ®Google Scholar
• Virca G. D., Mallya R. K., Pepys M. B., Schnebli H. P. Quantitation of human leukocyte elastase, cathepsin G, alpha‐2‐macroglobulin and alpha‐1‐proteinase inhibitor in osteoarthrosis and rheumatoid arthritis synovial fluids. Adv Exp Med Biol 1984; 167: 345–53
   PubMedGoogle Scholar
• Maeda S., Sawai T., Uzuli M., Takahaschi Y., Omoto H., Seki M., et al. Determination of interstitial collagenase (MMP‐1) in patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54: 970–5
   PubMedGoogle Scholar
• Lenarcic B., Gabrijelcic D., Rozman B., Drobnic‐Kosorok M., Turk V. Human cathepsin B and cysteine proteinase inhibitors (CPIs) in inflammatory and metabolic joint diseases. Biol Chem Hoppe Seyler 1988; 369(Suppl): 257–61
   PubMedGoogle Scholar
• Maciewicz R. A., Etherington D. J. Enzyme immunoassay for cathepsins B and L in synovial fluids from patients with arthritis. Biochem Soc Trans 1988; 16: 812–13
   Google Scholar
• Fukui I., Tanaka K., Murachi T. Extracellular appearance of calpain and calpastatin in the synovial fluid of the knee joint. Biochem Biophys Res Commun 1989; 162: 559–66
   PubMed Web of Science ®Google Scholar
• Gotoh H., Hagihara M., Nagatsu T., Iwata H., Miura T. Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Chem 1989; 35: 1016–18
   PubMedGoogle Scholar
• Maciewicz R. A., Wotton S. F., Etherington D. J., Duance V. C. Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L. FEBS Lett 1990; 269: 189–93
   PubMed Web of Science ®Google Scholar
• Huet G., Flipo R. M., Richet C., Thiebaut C., Demeyer D., Balduyck M., et al. Measurement of elastase and cysteine proteinases in synovial fluid of patients with rheumatoid arthritis, sero‐negative spondylarthropathies, and osteoarthritis. Clin Chem 1992; 38: 1694–7
   PubMedGoogle Scholar
• Lemaire R., Huet G., Zerimech F., Grard G., Fontaine C., Duquesnoy B., et al. Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast‐like cells. Br J Rheumatol 1997; 36: 735–43
   PubMedGoogle Scholar
• Muller‐Ladner U., Kriegsmann J., Gay R. E., Koopman W. J., Gay S., Chatham W. W. Progressive joint destruction in a human immunodeficiency virus‐infected patient with rheumatoid arthritis. Arthritis Rheum 1995; 38: 1328–32
   PubMedGoogle Scholar
• Keyszer G. M., Heer A. H., Kriegsmann J., Geiler T., Trabandt A., Keysser M., et al. Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization. Arthritis Rheum 1995; 38: 976–84
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Zerimech F., Huet G., Balduyck M., Degand P. Cysteine proteinase activity in synovial fluids measured with a centrifugal analyzer. Clin Chem 1993; 39: 1751–3
   PubMedGoogle Scholar
• Shimizu K., Hamamoto T., Hamakubo T., Lee W. J., Suzuki K., Nakagawa Y., et al. Immunohistochemical and biochemical demonstration of calcium‐dependent cysteine proteinase (calpain) in calcifying cartilage of rats. J Orthop Res 1991; 9: 26–36
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosenbrough N. J., Farr A. L., Randall R. J. Proteins measurement with folin phenol reagent. J Biol Chem 1951; 193: 265–75
   PubMed Web of Science ®Google Scholar
• Trabandt A., Gay R. E., Fassbender H. G., Gay S. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum 1991; 34: 1444–51
   PubMedGoogle Scholar
• Keyszer G., Redlich A., Haupl T., Zacher J., Sparmann M., Engethum U., et al. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase‐polymerase chain reaction and immunohistochemistry. Arthritis Rheum 1998; 41: 1378–87
   PubMedGoogle Scholar
• Lemaire R., Flipo R. M., Migaud H., Fontaine C., Huet G., Dacquembronne E., et al. Alternative splicing of the 5′ region of cathepsin B pre‐messenger RNA in rheumatoid synovial tissue. Arthritis Rheum 1997; 40: 1540–2
   PubMedGoogle Scholar
• Biroc S. L., Gay S., Hummel K. M., Palmer J., Spencer D., Sa S., et al. Cysteine protease activity is up‐regulated in joints of rats with adjuvant induced arthritis. Arthritis Rheum 1997; 40: S98
   PubMedGoogle Scholar
• Cunnane G., FitzGerald O., Hummel K. M., Gay R. E., Gay S., Bresnihan B. Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis. Rheumatology 1999; 38: 34–42
   PubMed Web of Science ®Google Scholar
• Hashimoto Y., Kakegawa H., Narita Y., Hachiya Y., Hayakawa T., Kos J., et al. Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis. Biochem Biophys Res Commun 2001; 283: 334–9
   PubMed Web of Science ®Google Scholar
• Yamamoto S., Shimizu K., Suzuki K., Nakagawa Y., Yamamuro T. Calcium‐dependent cysteine proteinase (calpain) in human arthritic synovial joints. Arthritis Rheum 1992; 35: 1309–17
   PubMedGoogle Scholar
• Hegen M., Niedobitek G., Klein C. E., Stein H., Fleischer B. The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J Immunol 1990; 144: 2908–14
   PubMed Web of Science ®Google Scholar
• Lapadula G., Iannone F., Zuccaro C., Covelli M., Patella V., Lobianco G., et al. Expression of membrane‐bound peptidases (CD10 and CD26) on human articular chondrocytes. Possible role of neuropeptidases in the pathogenesis of osteoarthritis. Clin Exp Rheumatol 1995; 13: 143–8
   PubMedGoogle Scholar
• Fleischer B. CD26: a surface protease involved in T‐cell activation. Immunol Today 1994; 15: 180–4
   PubMedGoogle Scholar
• Kamori M., Hagihara M., Nagatsu T., Iwata H., Miura T. Activities of dipeptidyl peptidase IV, prolyl endopeptidase, and collagenase‐like peptidase in synovial membrane for patients with rheumatoid arthritis and osteoarthritis. Biochem Med Metab Biol 1991; 45: 154–60
   PubMedGoogle Scholar
• Gerli R., Muscat C., Bertotto A., Bistoni O., Agea E., Tognellini R., et al. CD26 surface molecule involvement in T cell activation and lymphokine synthesis in rheumatoid and other inflammatory synovitis. Clin Immunol Immunopathol 1996; 80: 31–7
   PubMedGoogle Scholar
• Mizokami A., Eguchi K., Kawakami A., Ida H., Kawabe Y., Tsukada T., et al. Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis. J Rheumatol 1996; 23: 2022–6
   PubMed Web of Science ®Google Scholar
• Muscat C., Bertotto A., Agea E., Bistoni O., Ercolani R., Tognellini R., et al. Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients. Clin Exp Immunol 1994; 98: 252–6
   PubMed Web of Science ®Google Scholar
• Ahmed N. K., Martin L. A., Watts L. M., Palmer J., Thornburg L., Prior J., et al. Peptidyl fluoromethyl ketones as inhibitors of cathepsin B. Implication for treatment of rheumatoid arthritis. Biochem Pharmacol 1992; 44: 1201–7
   PubMed Web of Science ®Google Scholar
• Tanaka S., Murakami T., Horikawa H., Sugiura M., Kawashima K., Sugita T. Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV. Int J Immunopharmacol 1997; 19: 15–24
   PubMed Web of Science ®Google Scholar
• Yoshifuji H., Umehara H., Maruyama H., Itoh M., Tanaka M., Kawabata D., et al. Amelioration of experimental arthritis by a calpain‐inhibitory compound: regulation of cytokine production by E‐64‐d in vivo and in vitro. Int Immunol 2005; 17: 1327–6
   PubMed Web of Science ®Google Scholar